Andrew Hamer

Equibles does not estimate personal net worth.

Get an email with a short summary when Cardiol Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get CRDL alerts

About Andrew Hamer

Andrew Hamer has spoken on 1 investor event across 1 company, most recently for Cardiol Therapeutics Inc. on August 11, 2026. Cardiol Therapeutics Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Andrew Hamer on recent calls

“Cardiotherapeutics developed a formulation for cannabidiol that is fully synthetic and pharmaceutically manufactured. And the reason for that is the intriguing information that was coming forward about its anti-inflammatory characteristics, especially in cardiovascular diseases.”

Other, Cardiol Therapeutics Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference · August 11, 2026